Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-Human Fibrin Antibody (59D8)

Catalog #:   RHB99201 Specific References (55) DATASHEET
Host species: Mouse
Isotype: IgG1, kappa
Applications: IF, IHC, RIA, WB
Accession: P02675
Overview

Catalog No.

RHB99201

Species reactivity

Human

Host species

Mouse

Isotype

IgG1, kappa

Clonality

Monoclonal

Target

FGB, Fibrinogen beta chain, Fibrin

Concentration

2.31 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P02675

Applications

IF, IHC, RIA, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

59D8

Data Image
References

Strategic reuse of rapid antigen tests for coagulation status assessment: an integrated machine learning approach. [RHB99201]

A novel role for thioredoxin-related transmembrane protein TMX4 in platelet activation and thrombus formation

Neutrophil extracellular traps block endogenous and intravenous thrombolysis-induced fibrinolysis in large vessel occlusion acute ischemic stroke. [RHB99201]

Endoplasmic reticulum protein 29 negatively regulates platelet functions and thrombosis in mice. [RHB99201]

Pharmacovigilance insights into antibody-drug conjugates: a multi-database analysis of adverse events in leukemia treatment., PMID:40522479

IgA autoimmunity and coagulation among post-acute sequelae of SARS-CoV-2 infection (PASC) patients with persistent respiratory symptoms: a case-control study., PMID:40519899

Enfortumab vedotin induced interstitial lung disease: A first case report with pathological evidence from transbronchial lung cryobiopsy., PMID:40496844

Mechanism and biological significance of erythrocyte homoaggregation (rouleaux formation): temperature-dependent entropic liberation of water from cells and macromolecules., PMID:40441594

Babesia bigemina enolase binds to plasminogen and contains conserved B-cell epitopes that induce neutralizing antibodies in cattle., PMID:40403476

In vitro effects of Mim8 and combined Mim8-bypassing therapy on thrombin generation, thromboelastography and fibrin clot ultrastructure., PMID:40398047

Bite First, Bleed Later: How Philippine Trimeresurus Pit Viper Venoms Hijack Blood Clotting., PMID:40278683

Thrombotic Diathesis Combined With Connective Tissue Disease in a Chinese Teenage Male: A Case Report., PMID:40269468

MAPK Signaling and Angiopoietin-2 Contribute to Endothelial Permeability in Capillary Malformations., PMID:40235979

Five decades of successive establishment of hemophilia care in Thailand., PMID:40159660

Pseudothrombocytopenia and other conditions associated with spuriously low platelet counts., PMID:40145275

Surface-bound FXIII enhances deposition and straightness of fibrin fibers., PMID:40139391

Atypical presentation of H1N1-induced thrombotic microangiopathy with CD46 gene mutation
., PMID:40115863

Safety and Efficacy of Long-Term Treatment of Type 1 Plasminogen Deficient Patients With Intravenous Plasminogen Replacement Therapy., PMID:40099460

Post-transfusion activation of coagulation pathways during severe COVID-19 correlates with COVID-19 convalescent plasma antibody profiles., PMID:40091845

SARS-CoV-2 Placentitis: A Review of Pathologic Findings and Discussion of Differential Diagnosis., PMID:40090361

Endothelial cell activation enhances thromboinflammation in vaccine-induced immune thrombotic thrombocytopenia., PMID:40085945

Transcription factor RUNX1 regulates coagulation factor XIII-A (F13A1): decreased platelet-megakaryocyte F13A1 expression and clot contraction in RUNX1 haplodeficiency., PMID:39995753

Intravenous immunoglobulin prevents thrombosis in an endothelialized disease model of heparin-induced thrombocytopenia., PMID:39984158

Exploring Biomarkers to Predict Thrombogenic Risk in Pregnancy., PMID:39941603

Granulomatosis with Polyangiitis Initially Presenting as Frequent Urination Mimicking a Prostatic Abscess: A Case Report., PMID:39891392

Clinicopathological analysis of anti-VEGF drug-associated renal thrombotic microangiopathy: A case series and review of the literature., PMID:39879682

Protection of β2GPI-deficient mice from thrombosis reflects a defect in PAR3-facilitated platelet activation., PMID:39869832

Old and New Biomarkers in Idiopathic Recurrent Acute Pericarditis (IRAP): Prognosis and Outcomes., PMID:39798014

Ultrasensitive and high selectivity detection of fibrin using Y-shaped DNA-homing peptide doped probe on localized surface plasmon resonance platform., PMID:39788687

Bullous pemphigoid and hypercoagulability: a review., PMID:39772971

Inhibiting Tyrosine Kinase 2 Ameliorates Antiphospholipid Syndrome Nephropathy., PMID:39742289

Impact of antiphospholipid syndrome on placenta and uterine NK cell function: insights from a mouse model., PMID:39732740

The sequence 581Ser-610Val in the fibrinogen Aα chain is responsible for the formation of complexes between plasminogen and αC-regions of fibrin(ogen)., PMID:39687172

Rapid prediction of acute thrombosis via nanoengineered immunosensors with unsupervised clustering for multiple circulating biomarkers., PMID:39661669

Prognostic significance of serum interleukin-6 in severe/critical COVID-19 patients treated with tocilizumab: a detailed observational study analysis., PMID:39609511

Anti-Modified Peptide Antibodies (AMPAs) in Rheumatoid Arthritis: Study of the Diagnostic Value of Citrullinated, Homocitrullinated, and Acetylated Fibrin/Filaggrin Chimeric Peptides., PMID:39594151

Non-bacterial thrombotic endocarditis: a clinical and pathophysiological reappraisal., PMID:39565324

Successful treatment for a patient with antiphospholipid syndrome and decreased protein S activity exacerbated by heparin-induced thrombocytopenia: A case report., PMID:39533629

Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8): a prospective, multicentre, open-label, randomised, phase 3a trial., PMID:39521008

Eosinophilic cationic protein and D-Dimer are potential biomarkers to predict response to antihistamines but not to omalizumab in chronic spontaneous urticaria., PMID:39467078

The Effect of Tocilizumab on the outcome of patients with severe COVID-19 with cytokine storm syndrome in a sample of Iraqi patients., PMID:39434284

Risk Factors for Renal Involvement in Childhood Henoch-Schonlein Purpura (IgA Vasculitis)., PMID:39410700

Novel Chimeric Peptides Based on the Enolase Peptide Antigen (CEP-1) Bearing Three Post-Translational Modifications (Citrullination, Homocitrullination and Acetylation) for Determining the Diagnosis and Severity of Rheumatoid Arthritis., PMID:39408982

Encephalomyelitis and serositis caused by Chlamydia pecorum in buffalo calves from Brazil., PMID:39389928

Fibrinogen induces inflammatory responses via the immune activating receptor LILRA2., PMID:39376567

Autologous platelet concentrates as adjuvant in the surgical management of medication-related osteonecrosis of the jaw., PMID:39345044

Interfering antibodies may contribute to elevated D-dimer: a case report., PMID:39342404

Hypochloremia: A Potential Indicator of Poor Outcomes in COVID-19., PMID:39336455

Development and Epitope Mapping of Seven Mouse Anti-Human Coagulation Factor XIII-B Subunit Monoclonal Antibodies., PMID:39320988

A smartphone-based multichannel magnetoelastic immunosensor for acute aortic dissection supplementary diagnosis., PMID:39305762

The potential role of dyslipidemia in COVID-19 severity among Iraqi patients., PMID:39269829

A single-domain antibody targeting factor XII inhibits both thrombosis and inflammation., PMID:39266545

Fibrinogenolytic potential of venoms of medically important Brazilian snakes., PMID:39233288

Splenic cyst deroofing complicated with B lymphoma., PMID:39232740

A novel role for thioredoxin-related transmembrane protein TMX4 in platelet activation and thrombus formation. [RHB99201]

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1860

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human Fibrin Antibody (59D8) [RHB99201]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only